351 related articles for article (PubMed ID: 25482931)
1. Liposome-coated lipoplex-based carrier for antisense oligonucleotides.
Wyrozumska P; Meissner J; Toporkiewicz M; Szarawarska M; Kuliczkowski K; Ugorski M; Walasek MA; Sikorski AF
Cancer Biol Ther; 2015; 16(1):66-76. PubMed ID: 25482931
[TBL] [Abstract][Full Text] [Related]
2. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
3. Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibody.
Meissner JM; Toporkiewicz M; Czogalla A; Matusewicz L; Kuliczkowski K; Sikorski AF
J Control Release; 2015 Dec; 220(Pt A):515-528. PubMed ID: 26585505
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes.
Han M; Chen JL; Hu Y; He CL; Shuai WP; Yu JH; Chen HL; Liang WQ; Mayumi T; Shinsaku N; Gao JQ
J Biosci Bioeng; 2008 Sep; 106(3):243-7. PubMed ID: 18929999
[TBL] [Abstract][Full Text] [Related]
5. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
6. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
7. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
8. Ca(2+)-mediated anionic lipid-plasmid DNA lipoplexes. Electrochemical, structural, and biochemical studies.
Barrán-Berdón AL; Yélamos B; Malfois M; Aicart E; Junquera E
Langmuir; 2014 Oct; 30(39):11704-13. PubMed ID: 25211646
[TBL] [Abstract][Full Text] [Related]
9. Hydration of lipoplexes commonly used in gene delivery: follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry.
Hirsch-Lerner D; Barenholz Y
Biochim Biophys Acta; 1999 Nov; 1461(1):47-57. PubMed ID: 10556487
[TBL] [Abstract][Full Text] [Related]
10. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
11. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
Zuidam NJ; Barenholz Y
Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
[TBL] [Abstract][Full Text] [Related]
12. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.
Stuart DD; Kao GY; Allen TM
Cancer Gene Ther; 2000 Mar; 7(3):466-75. PubMed ID: 10766353
[TBL] [Abstract][Full Text] [Related]
13. [Biodistribution and hepatocytes targeting of cationic liposomes surface-modified with sterylglucoside and golyethylene glycol].
Shi J; Yan WW; Qi XR; Yang L; Zhang L
Yao Xue Xue Bao; 2004 Jul; 39(7):551-5. PubMed ID: 15493849
[TBL] [Abstract][Full Text] [Related]
14. Aspects of nonviral gene therapy: correlation of molecular parameters with lipoplex structure and transfection efficacy in pyridinium-based cationic lipids.
Parvizi P; Jubeli E; Raju L; Khalique NA; Almeer A; Allam H; Manaa MA; Larsen H; Nicholson D; Pungente MD; Fyles TM
Int J Pharm; 2014 Jan; 461(1-2):145-56. PubMed ID: 24296044
[TBL] [Abstract][Full Text] [Related]
15. Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes.
Peddada LY; Garbuzenko OB; Devore DI; Minko T; Roth CM
J Control Release; 2014 Nov; 194():103-12. PubMed ID: 25192941
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Lipid Types and Liposomal Formulations on Osteoblast Adiposity and Mineralization.
Chang SF; Yeh CC; Chen PJ; Chang HI
Molecules; 2018 Jan; 23(1):. PubMed ID: 29301300
[TBL] [Abstract][Full Text] [Related]
17. Effect of lipid composition on the structure and theoretical phase diagrams of DC-Chol/DOPE-DNA lipoplexes.
Muñoz-Ubeda M; Rodríguez-Pulido A; Nogales A; Martín-Molina A; Aicart E; Junquera E
Biomacromolecules; 2010 Dec; 11(12):3332-40. PubMed ID: 21058732
[TBL] [Abstract][Full Text] [Related]
18. Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors.
Chen Y; Sun J; Lu Y; Tao C; Huang J; Zhang H; Yu Y; Zou H; Gao J; Zhong Y
Int J Nanomedicine; 2013; 8():1573-93. PubMed ID: 23637529
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery.
Mokhtarieh AA; Cheong S; Kim S; Chung BH; Lee MK
Biochim Biophys Acta; 2012 Jul; 1818(7):1633-41. PubMed ID: 22465072
[TBL] [Abstract][Full Text] [Related]
20. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.
Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B
J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
